Once the tumours were palpable, the mice were treated with control, oxaliplatin monotherapy, the IMPDH2 inhibitor MMF monotherapy, or a combination of oxaliplatin (10 mg/kg every 3 days) and MMF (120 mg/kg twice a day) for 3 weeks. This evidence concerns the gene IMPDH2 and neoplasm.